Poster Instructions and Assignment List

POSTER, STUDENT POSTER, CLINICAL VIGNETTE POSTER, AND INNOVATION ACADEMY POSTER
PRESENTATION INSTRUCTIONS
POSTER Viewing:
Location:
Thursday, April 16 and Friday, April 17
Coles Ballroom (PEI Convention Centre)
Viewing Times Thursday April 16:
Morning break 11:00 am to 12:30 pm
o STUDENT POSTER PRESENTERS (SP) MUST
BE AT THEIR POSTERS TO ANSWERS
QUESTIONS!
Lunch between 12:30 pm to 1:00 pm
Welcome Reception 6:30 pm to 8:30 pm
Viewing Times Friday April 17:
Morning break 11:00 am to 12:30 pm
o POSTER (P), CLINICAL VIGNETTE (CV), AND
INNOVATION ACADEMY (IA) POSTER
PRESENTERS MUST BE AT THEIR POSTERS
TO ANSWERS QUESTIONS!
Lunch between 12:30 pm to 1:00 pm
Poster Set-Up Time:
Wednesday April 15 between 4:00 pm – 6:00 pm
Thursday April 16 between 7:00 am – 10:00 am
Poster Removal Time:
Friday April 17 at 1:00 pm
* Should you require assistance onsite, please go to the Registration Desk.
GENERAL INFORMATION
Poster Boards are 4ft high x 8ft wide.
A good poster size is 3ft high x 6ft wide.
Velcro (male side) and pin friendly.
All presenting authors MUST be registered for the annual conference, no later than Monday March 2, 2015. If
registration is not complete by this date, the abstract will be REMOVED and will NOT be published.
STUDENT POSTER Presenters must fill in and submit to ([email protected]) a Student/Technologist/Trainee
Awards Competition Form by Monday March 2, 2015. http://ammi.ca/media/75949/Student-TechnologistTrainee%20Award%20Form%20-%20EN%20v2.pdf
HOTEL AND CONFERENCE REGISTRATION INFORMATION
The Hotel Room Blocks are full at both the Delta Prince Edward and Holman Grand. Please contact Stephanie
Wolkowycki at the AMMI Canada Secretariat at [email protected] to make arrangements.
REGISTRATION
Register now: http://ammi.emsreg.com/ammi15/public/splash1.aspx
STUDENT POSTER PRESENTATION ASSIGNMENT LIST
Serial No. Prog. No.
0003 SP01
0004 SP02
Initial
Bahareh
Last name
Ghadaki
Title
COPD Symptom and Disease Screening in an HIV Population
Withdrawn
0007 SP03
Gabriel
Chan
0021 SP04
Chris
Lata
0026 SP05
Hong Yuan
Zhou
0028 SP06
Ramzi
Fattouh
0031 SP07
Nipunie
Rajapakse
0035 SP08
Roshan
Priyantha
0036 SP09
Anthony
Bai
0040 SP10
Carla
Penney
0045 SP11
Jasmine
Chong
0046 SP12
Sylvain
Lother
0047 SP13
Manal
Rostom
0048 SP14
0049 SP15
Mohammad Alghounaim
0051 SP16
Sumana
Fathima
0052 SP17
Nathan
Zelyas
0056 SP18
Constantina
Boikos
Characterization of Canadian Hospital Infection Control Practices
for Caregivers and Visitors
Antimicrobial Prescribing Practices in the Treatment of
Suspected UTI in the Elderly in the Emergency Department: a
Retrospective Single Centre Study
The Infectiousness and/or Virulence of Isoniazid-Resistant vs.
Susceptible Pulmonary Tuberculosis: A Case-Control Study in
Alberta
Meropenem MIC Profile of Carbapenemase-Producing
Enterobacteriaceae in a Low Prevalence Region
Creation of A Novel Pediatric Antimicrobial Stewardship
Advanced Fellowship Training Program
Emerging Antimicrobial Resistance among Staphylococcus
Pseudintermedius, a Potential Zoonoses of Canine Origin
Positive Impact of Infectious Disease Consultation on Quality of
Care, Mortality and Length of Stay in Staphylococcus aureus
Bacteremia: Results from a Large Multicenter Cohort Study
Prospective Observational Study of Diagnosis of Urinary Tract
Infection and Response to Therapy in Long Term Care
Molecular Epidemiology of Vancomycin Heteroresistant
Coagulase-Negative Staphylococci in a Neonatal Intensive Care
Unit in Quebec
Increasing Incidence of Group C and Group G Streptococcal
Bacteremia Attributed to Increased Bacterial Virulence Factors
and Poor Outcomes
Antimicrobial Stewardship in Primary Care: An Evaluation of the
Management of Acute Uncomplicated Cystitis in a Family Health
Team
Withdrawn
Clostridium difficile Infections (CDI) in Children: Are we
overestimating rates just because of the diagnostic method
used?
Surveillance of Human Parainfluenza Types 1-4 and Association
with Acute Lower Respiratory Tract Infections in Hospitalized
Cases, Alberta, Canada (2010 – 2013)
Clostridium difficile infection in solid organ transplant recipients
at a tertiary care centre during 2006-2013
Safety of the Live-Attenuated Intranasal Influenza Virus (LAIV)
Vaccine in Children and Adolescents with Cystic Fibrosis and
their Healthy Siblings
Serial No. Prog. No.
0058 SP19
Initial
Jianbo
Last name
Zhang
0060 SP20
Élise
Fortin
0065 SP21
Kristin Y.
Popiel
0066 SP22
Diana
Whellams
0068 SP23
Geoffrey
Shumilak
0073 SP24
Yan
Chen
0077 SP25
Chris
Le
0078 SP26
Lauren
Goodliffe
0080 SP27
Derek R.
MacFadden
0082 SP28
Luke
Ryan
0084 SP29
Andrew
Denisuik
0085 SP30
Samuel
0086 SP31
0089 SP32
Yannick
Sneha
De L’ÉtoileMorel
Emond
Suresh
0090 SP33
Shazia
Masud
0091 SP34
Erika
Koeck
0092 SP35
Alexandra
Mcfarlane
0094 SP36
Galit
Pomeranz
0098 SP37
David
Harris
Title
Severe Skin Lesions Induced by a Predominant CA-MRSA Strain
USA300 are Associated with a Unique Neutrophil Response and
Involvement of Proteinase Activated Receptors (PARs)
Surveillance of Antimicrobial Use in Québec Acute Care
Hospitals: A Dream or Almost Reality?
Usefulness of Fecal Calprotectin and Serum Procalcitonin in
Predicting a Positive C. difficile Toxin Gene Polymerase Chain
Reaction Assay
Successful use of intrathecal colistin in a case of Pseudomonas
aeruginosa ventriculitis: a case report and brief review of the
literature
Prevalence of Anemia in the Saskatchewan Population with HIV
Infection
Rapid Identification of Bacteria in Positive Blood Cultures Using
Smudge Plate Preparation and MALDI-TOF MS System
Assessment of the management of suspected urinary tract
infections for identification of targeted antimicrobial
stewardship interventions
Clinical Features and Outcomes of Influenza Infection in
Community Dwelling Older Adults Presenting to Six Urban
Emergency Departments
Engaging Infectious Diseases And Microbiology Residents in
Improving the Value of Healthcare: Choosing Wisely
Incidence and Outcomes of Hospital-acquired C. difficile
Infection at a Large Community Hospital Before and After a
Multipronged Prevention and Management Initiative
The Continued Rise of Extended-Spectrum β-LactamaseProducing Escherichia coli in Canadian Hospitals: CANWARD
2007-2013
Inpatient Care of Community Acquired Pneumonia:
Opportunities for Improvement
Feasibility of UV-C light disinfection in a Canadian hospital.
Non-Polio Enterovirus Types Associated with Acute Flaccid
Paralysis – A Systematic Review
Evaluation of Matrix Assisted Laser Desorption Ionization-Time
of Flight Mass Spectrometry (MALDI-TOF MS) for Yeast
Identification
Xpert MTB/RIF as a Supplemental Test to Acid-Fast Bacilli
Sputum Microscopy in the Diagnosis of Tuberculosis: Potential
Resource Savings
Hospitalized Influenza Patients during 2013-2014; a Comparison
of ICU and Ward Treated Patients including Antimicrobial
Therapy, Adverse Events, and Outcomes
Clinical Spectrum of Rhinovirus Infections in Hospitalized
Children in Israel - a single center's experience
Prosthetic Joint Infections: Patterns of Practice for Diagnosis,
Management, and Outcome
Revised April 7, 2015
Page 2 of 6
Serial No. Prog. No.
0100 SP38
0101 SP39
Initial
Emilie
Amy
Last name
Vallieres
Delorme
0103 SP40
Hilal
Al Sidairi
0150 SP41
Claudia
0121 SP42
Byron
Martinez de
la Peña
Berenger
0125 SP43
Angela
Ma
0127 SP44
Dahn
Jeong
0131 SP45
Alexander
Lawandi
0137 SP46
Cindy
Lam
0139 SP47
Aaron
Campigotto
0144 SP48
Gauri
Shah
0145 SP49
William J.
Connors
Title
Urinary Biomarkers in Patients with Cystic Fibrosis
Carbon Source Modulates Paradoxical Growth Effect of
Caspofungin in Candida albicans
Cost-effectiveness of MALDI-TOF MS in Clinical Analysis of Urine
Specimens in Nova Scotia
Role of Type IV Pili in the Clostridium difficile Pathogenic
Program
Detection and Characterization of a 2014 Escherichia coli
O157:H7 Outbreak in Alberta by Multiple Molecular Methods
Including Whole Genome Sequencing
Heat Resistant Shiga Toxin-Producing Escherichia coli (STEC)
from Clinical Cases in Alberta
The Use of Antibiotics in the Treatment of Skin and Soft Tissue
Infections in Selected First Nations Communities
The Role of Inter-Hospital Sample Transport in Total Assay Time
for Microbiological Screening Tests
Investigation of Matrix Assisted Laser Desorption/Ionisation
Time-of-Flight Mass Spectrometry (MALDI-TOF MS) for
detection of Clostridium difficile toxin A and B from stool
samples
Cumulative antimicrobial susceptibility data from ICUs at one
institution: should data be combined?
Infectious Complications After Central Venous Catheter Repair
in Pediatric Patients
Acute Odontogenic Infection Management in the OPAT Clinic
Setting: a Quality Improvement Study in Calgary, Alberta
Revised April 7, 2015
Page 3 of 6
POSTER PRESENTATION ASSIGNMENT LIST
Last name
Title
Serial
Prog.
No.
No.
0005 P01
Initial
Nawal
Al Musayeib
0006 P02
Adrian
Shephard
0011 P03
Barbara M.
Willey
0015 P04
0017 P05
Valan Arasu
Mariadhas
0022 P06
Maheen
Abidi
0029 P07
0033 P08
Carole
Michael
Lavigne
McConnell
0037 P09
Anthony
Bai
0039 P10
Neal
Irfan
0041 P11
Khurram
Rana
0043 P12
Eugene S.
Swenson
0044 P13
Eugene S.
Swenson
0053 P14
Hong Yuan
Zhou
0054 P15
Min-Kuang
Lee
0055 P16
Ramzi
Fattouh
0118 P17
Paul N.
Levett
0149 P18
Kathleen
Whyte
0072 P19
Muhammad Rehan
Antiprotozoal potential of phenolic compounds from Kleinia
odora
In-vitro Antiviral Action of Amylmetacresol (AMC) and 2,4Dichlorobenzyl Alcohol (BCDA) Against the Respiratory
Pathogen Parainfluenza Type 3
Use of Temocillin Resistance (TemR) as a Phenotypic Diffusion
Marker for Class D Carbapenemases (Carb) in CarbapenemaseProducing Organisms (CPO)
Withdrawn
Novel Isosteviol Isolated From Pittosporum tetraspermum
Exhibited Antimicrobial, Antibiofilm And Anticancer Activities
CYP2C19*17 Genetic Polymorphism and Therapeutic Challenges
in an Allogeneic Stem Cell Transplant Recipient with Invasive
Pulmonary Aspergillosis
Nanoparticles to Target HIV Reservoirs
Increased Recovery and Detection of Pathogens Using Copan’s
WASPLab™ Total Laboratory Automation (TLA)
Usefulness of previous methicillin-resistant Staphylococcus
aureus screening results in guiding empiric therapy for S. aureus
bacteremia
Inadequate Symptom Documentation of Urinary Tract Infection
in the Medical Chart
All-Oral 12-Week Combination Treatment with Daclatasvir
(DCV) and Sofosbuvir (SOF) in Patients Infected with HCV
Genotype (GT) 3: ALLY-3 Phase 3 Study
All-oral, Fixed-dose Combination Therapy with
Daclatasvir/Asunaprevir/BMS-791325 for Non-cirrhotic Patients
with Chronic HCV Genotype 1 Infection: UNITY-1 Phase 3 SVR12
Results
All-oral Fixed-dose Combination Therapy with
Daclatasvir/Asunaprevir/BMS-791325, ± Ribavirin, for Patients
with Chronic HCV Genotype 1 Infection and Compensated
Cirrhosis: UNITY-2 Phase 3 SVR12 Results
Recurrent Micafungin-Resistant Candida glabrata Candidemia
with Prolonged Micafungin Treatment for Multiple Intraabdominal Abscesses: A Case Report
Active Environmental Surveillance of Lyme Disease in British
Columbia (2013 and 2014)
Investigating the Potential Role of Bacterial Infection in
Granulomatosis with Polyangiitis (GPA)
Evaluation of antigen detection for confirmatory testing of
hepatitis C virus infection
Recurrent Invasive Haemophilus influenzae Type a Infection in
an Infant
Optimizing the Diagnostic Yield of Joint Fluid/ Tissue Culture for
Revised April 7, 2015
Page 4 of 6
Serial
No.
Prog.
No.
Initial
Last name
0097 P20
Jason
Leblanc
0099 P21
Melissa
Kissoon
0109 P22
Tony
Mazzulli
0114 P23
Kimberley
Savage
0062 P24
0122 P25
Sarah
West
0134 P26
Vanessa
0135 P27
Joel
MeierStephenson
Kettner
0146 P28
P29
0018 P30
Mary Louise
Graham
Kamran
Kadkhoda
0107 P31
Rabee
Adwan
0048 P32
Caroline
Quach
Title
the Hamilton Regional Laboratory Medicine Program
Pushing the Limits of Chemistry Point-of-Care Testing for the
Management of Patients under Investigation for Ebola Virus
Disease
Increase in Methicillin-susceptible Staphylococcus aureus with
Reduced Susceptibility to Triclosan Over the Last 20 Years
Characterizing the resistance related mutations in the NS3
protease of Hepatitis C-infected Ontario patients.
Iron Restriction to Clinical Isolates of Candida albicans by DIBI
Inhibits Growth and Increases Sensitivity to Azole Antifungals
Withdrawn
SNAP—Sepsis Now a Priority: Development and Implementation
of a Sepsis Algorithm in the Emergency Department of an
Academic Hospital
What a Fluke: A Case of Biliary Fascioliasis in a Recent
Immigrant
AMR, Public Health, and Knowledge Translation: A Forward
Approach
Oversight of Human and Animal Pathogens and Toxins
Withdrawn
The Retrospective Study of the Prevalence and Clinical
Significance of Hepatitis B Virus Precore and Basal Core
Promoter Variants
Mycoplasma pneumoniae Infection in Children Less Than Five
Years of Age; a 17 Years Review
Emergency Department Utilization of Respiratory Virus Testing
for Febrile Young Infants Under Six Weeks of Age
Revised April 7, 2015
Page 5 of 6
Serial
No.
Serial
No.
INNOVATION ACADEMY POSTER PRESENTATION LIST
Last name
Title
Prog.
No.
IA01
Initial
Patrick
Dolcé
IA02
Candy
Rutherford
IA03
Yanal M.
Murad
Prog.
No.
Cv01
Initial
Syed
Ala
CV02
CV03
CV04
Glenn
Patriquin
Titus
Wong
Real-Time Computer-Generated Alerts to Select Interventions and
Optimize an Antimicrobial Stewardship Program
Inclusion of Rhinovirus/Enterovirus in Routine Respiratory Testing
Enabled Timely Detection of Enterovirus D68 in the Hamilton Area
Preventing C. difficile Infection by Screening Hospital Admissions
for C. difficile
CLINICAL VIGNETTE POSTER PRESENTATION LIST
Last name
Title
Adenovirus Interstitial Nephritis in a Patient with Renal
Transplant
A Case of Capnopytophaga canimorsus Meningitis
Withdrawn
Atypical Case of Atypical Pneumonia: Disseminated Mycoplasma
hominis Infection in a Double Lung Transplant Recipient
Revised April 7, 2015
Page 6 of 6